Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Exonate

1 clinical trial

Clinical trial
An Open-label, Multiple Dose, Dose Escalation Study to Evaluate the Safety and Tolerability of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene
Status: Completed, Estimated PCD: 2019-10-02